Systemic treatment of adult atopic dermatitis

MeSH terms

• Administration, Cutaneous
• Administration, Oral
• Adrenal Cortex Hormones / administration & dosage
• Adrenal Cortex Hormones / adverse effects
• Adrenal Cortex Hormones / pharmacokinetics
• Adult
• Age of Onset
• Antibodies, Monoclonal / administration & dosage
• Antibodies, Monoclonal / adverse effects
• Antibodies, Monoclonal / pharmacokinetics
• Biological Availability
• Clinical Trials as Topic
• Dermatitis, Atopic* / diagnosis
• Dermatitis, Atopic* / epidemiology
• Dermatitis, Atopic* / genetics
• Dermatitis, Atopic* / therapy
• Dermatologic Agents* / administration & dosage
• Dermatologic Agents* / adverse effects
• Dermatologic Agents* / pharmacokinetics
• Disease Management*
• Filaggrin Proteins
• Genetic Predisposition to Disease
• Histamine Antagonists / administration & dosage
• Histamine Antagonists / adverse effects
• Histamine Antagonists / pharmacokinetics
• Humans
• Immunosuppressive Agents* / administration & dosage
• Immunosuppressive Agents* / adverse effects
• Immunosuppressive Agents* / pharmacokinetics
• Intermediate Filament Proteins / genetics
• Mycophenolic Acid / administration & dosage
• Mycophenolic Acid / adverse effects
• Mycophenolic Acid / analogs & derivatives
• Mycophenolic Acid / pharmacokinetics